Cardiac toxicity of mediastinal radiotherapy: Which are the critical structures? [3]

Journal of Clinical Oncology

Volumn 23, Issue 15, 2005, Pages 3634-3636

  Vordermark, Dirk ^a   Seufert, Ines ^a   Schwab, Franz ^a   Flentje, Michael ^a   Kung, Margret ^a   Angermann, Christiane ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60;

CANCER RADIOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; COMPUTER ASSISTED TOMOGRAPHY; CONSTRICTIVE PERICARDITIS; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART MUSCLE CONDUCTION DISTURBANCE; HODGKIN DISEASE; HUMAN; LETTER; MEDIASTINUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDITIS; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RESTRICTIVE CARDIOMYOPATHY; VALVULAR HEART DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GERMANY; HEART; HEART DISEASE; MALE; NOTE; PATHOPHYSIOLOGY; PREVALENCE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RADIATION RESPONSE; RETROSPECTIVE STUDY; RISK ASSESSMENT;

COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HEART; HEART DISEASES; HODGKIN DISEASE; HUMANS; MALE; MEDIASTINUM; PREVALENCE; RADIATION INJURIES; RADIATION PROTECTION; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 20644456697     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.288     Document Type: Letter

References (11)

1. Adams MJ, Lipsitz SR, Colan SD, et al: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22:3139-3148, 2004
2. Knobel H, Loge JH, Lund MB, et al: Late medical complications and fatigue in Hodgkin's disease survivors. J Clin Oncol 19:3226-3233, 2001
3. Glanzmann C, Kaufmann P, Jenni R, et al: Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 46:51-62, 1998
4. Engert A, Schiller P, Josting A, et al: Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21:3601-3608, 2003
5. Stromberg JS, Sharpe MB, Kim LH, et al: Active breathing control (ABC) for Hodgkin's disease: Reduction in normal tissue irradiation with deep inspiration and implications for treatment. Int J Radiat Oncol Biol Phys 48:797-806, 2000
6. Rutqvist LE, Lax I, Fornander T, et al: Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22:887-896, 1992
7. Constantine G, Shan K, Flamm SD, et al: Role of MRI in clinical cardiology. Lancet 363:2162-2171, 2004
8. Petersch B, Bogner J, Fransson A, et al: Effects of geometric distortion in 0.2 T MRI on radiotherapy treatment planning of prostate cancer. Radiother Oncol 71:55-64, 2004
9. Adams MJ, Hardenbergh PH, Constine LS, et al: Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol 45:55-75, 2003
10. Coltart RS, Roberts JT, Thom CH, et al: Severe constrictive pericarditis after single 16 MeV anterior mantle irradiation for Hodgkin's disease. Lancet 1:488-489, 1985
11. Glanzmann C, Huguenin P, Lütolf UM, et al: Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 30:43-54, 1994